Medley Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $30.1M

  • Investors
  • 3

Medley Therapeutics General Information

Description

Operator of a biotechnology company intended to help in the regeneration of genes. The company develops genetic medicines that leverage the latest gene therapy technologies to reverse and cure severe diseases, providing patients with a means to live a healthier life.

Contact Information

Formerly Known As
YAP Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 26051 Merit Circle
  • Suite 102
  • Laguna Hills, CA 92653
  • United States
+1 (949)
Primary Industry
Biotechnology
Corporate Office
  • 26051 Merit Circle
  • Suite 102
  • Laguna Hills, CA 92653
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medley Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 31-Jan-2022 $30.1M Completed Generating Revenue
1. Later Stage VC (Series A) 01-Mar-2021 Completed Generating Revenue
To view Medley Therapeutics’s complete valuation and funding history, request access »

Medley Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Medley Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Medley Therapeutics Patents

Medley Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024006898-A2 Gene therapy of hippo signaling improves heart function in a clinically relevant model Inactive 29-Jun-2022
WO-2024006898-A3 Gene therapy of hippo signaling improves heart function in a clinically relevant model Inactive 29-Jun-2022
JP-2025524525-A Hippo signaling gene therapy improves cardiac function in clinically relevant models Pending 29-Jun-2022 C12N15/113

Medley Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medley Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority
Fjord Ventures Venture Capital Minority
ArrowMark Partners Asset Manager Minority
To view Medley Therapeutics’s complete investors history, request access »

Medley Therapeutics FAQs

  • When was Medley Therapeutics founded?

    Medley Therapeutics was founded in 2016.

  • Where is Medley Therapeutics headquartered?

    Medley Therapeutics is headquartered in Laguna Hills, CA.

  • What is the size of Medley Therapeutics?

    Medley Therapeutics has 6 total employees.

  • What industry is Medley Therapeutics in?

    Medley Therapeutics’s primary industry is Biotechnology.

  • Is Medley Therapeutics a private or public company?

    Medley Therapeutics is a Private company.

  • What is the current valuation of Medley Therapeutics?

    The current valuation of Medley Therapeutics is .

  • What is Medley Therapeutics’s current revenue?

    The current revenue for Medley Therapeutics is .

  • How much funding has Medley Therapeutics raised over time?

    Medley Therapeutics has raised $31.1M.

  • Who are Medley Therapeutics’s investors?

    BCM Ventures, Fjord Ventures, and ArrowMark Partners have invested in Medley Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process